These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34722632)

  • 1. A Myeloid Signature-Based Nomogram Predicts the Postoperative Recurrence of Intrahepatic Cholangiocarcinoma.
    Liang J; Zhou H; Huang XQ; Liu YF; Zhang L; He D; Cui Y; Guo J; Hu K; Wu C
    Front Mol Biosci; 2021; 8():742953. PubMed ID: 34722632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma.
    Zhang R; Li Q; Fu J; Jin Z; Su J; Zhang J; Chen C; Geng Z; Zhang D
    BMC Cancer; 2021 Feb; 21(1):112. PubMed ID: 33535978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of Nomograms for Predicting Cancer-Specific Survival in Elderly Patients with Intrahepatic Cholangiocarcinoma After Liver Resection: A Competing Risk Analysis.
    Wang T; Zhang J; Wang W; Yang X; Kong J; Shen S; Wang W
    Cancer Manag Res; 2020; 12():11015-11029. PubMed ID: 33173335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence Trend and Competing Risk Analysis of Patients With Intrahepatic Cholangiocarcinoma: A Population-Based Study.
    Xing H; Tan B; Yang C; Zhang M
    Front Med (Lausanne); 2022; 9():846276. PubMed ID: 35433765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of a Nomogram for Differentiating Combined Hepatocellular Cholangiocarcinoma From Intrahepatic Cholangiocarcinoma.
    Wang T; Wang W; Zhang J; Yang X; Shen S; Wang W
    Front Oncol; 2020; 10():598433. PubMed ID: 33363028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of sarcomatoid change in patients with intrahepatic cholangiocarcinoma and prognosis after surgical liver resection: A Propensity Score Matching analysis.
    Wang T; Kong J; Yang X; Shen S; Zhang M; Wang W
    J Surg Oncol; 2020 Mar; 121(3):524-537. PubMed ID: 31867746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression Patterns and Post-Progression Survival in Recurred Intrahepatic Cholangiocarcinoma Patients: A Novel Prognostic Nomogram Based on Multicenter Cohorts.
    Zhao C; He C; Lu J; Huang X; Chen C; Lin X
    Front Oncol; 2022; 12():832038. PubMed ID: 35463346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified staging system of positive lymph nodes based nomogram in intrahepatic cholangiocarcinoma.
    Zhao C; Li X; Luo L; Chen C; He C
    Cancer Cell Int; 2023 Jul; 23(1):148. PubMed ID: 37516863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma.
    Zou W; Wang Z; Wang F; Li L; Liu R; Hu M
    BMC Cancer; 2021 May; 21(1):608. PubMed ID: 34034689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Preoperative Inflammation-Based Prognostic Scores in Patients With Intrahepatic Cholangiocarcinoma: A Multicenter Cohort Study.
    He C; Zhao C; Lu J; Huang X; Chen C; Lin X
    Front Oncol; 2021; 11():672607. PubMed ID: 34221991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of pretreatment serum lipids predict responses to PD-1 inhibitor treatment in advanced intrahepatic cholangiocarcinoma.
    Yang Z; Zhang D; Sima X; Fu Y; Zeng H; Hu Z; Hou J; Pan Y; Zhang Y; Zhou Z; Chen M; Hu D
    Int Immunopharmacol; 2023 Feb; 115():109687. PubMed ID: 36628893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Establishment and validation of a nomogram to predict overall survival of patients with gastric neuroendocrine neoplasms].
    Wang YL; Guo Y; Zhang RH; Chen LH; Yang YJ; Wang W; Chen J; Zhou ZW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):883-888. PubMed ID: 34674463
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel prognostic nomogram for colorectal cancer liver metastasis patients with recurrence after hepatectomy.
    Liang JY; Lin HC; Liu J; Wang DS; Yuan YF; Li BK; Zheng Y; Wu XJ; Chen G; Wang FH; Wang ZQ; Pan ZZ; Wan DS; Xu RH; Li YH
    Cancer Med; 2021 Mar; 10(5):1535-1544. PubMed ID: 33539664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.
    Hyder O; Marques H; Pulitano C; Marsh JW; Alexandrescu S; Bauer TW; Gamblin TC; Sotiropoulos GC; Paul A; Barroso E; Clary BM; Aldrighetti L; Ferrone CR; Zhu AX; Popescu I; Gigot JF; Mentha G; Feng S; Pawlik TM
    JAMA Surg; 2014 May; 149(5):432-8. PubMed ID: 24599477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].
    Luo XY; Du CY; Wei XF; Jiang N; Li M; Liao R
    Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):124-129. PubMed ID: 29397626
    [No Abstract]   [Full Text] [Related]  

  • 16. An Integrated Nomogram Combining Clinical Factors and Microtubule-Associated Protein 1 Light Chain 3B Expression to Predict Postoperative Prognosis in Patients with Intrahepatic Cholangiocarcinoma.
    Chen L; Fu H; Lu T; Cai J; Liu W; Yao J; Liang J; Zhao H; Zhang J; Zheng J; Zhang Y; Yang Y
    Cancer Res Treat; 2020 Apr; 52(2):469-480. PubMed ID: 31588704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomogram based on inflammatory indices for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
    Chen L; Zeng F; Yao L; Fang T; Liao M; Long J; Xiao L; Deng G
    Cancer Med; 2020 Feb; 9(4):1451-1461. PubMed ID: 31903730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genomic-clinical nomogram predicting recurrence-free survival for patients diagnosed with hepatocellular carcinoma.
    Kong J; Wang T; Shen S; Zhang Z; Yang X; Wang W
    PeerJ; 2019; 7():e7942. PubMed ID: 31687273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and validation of a nomogram model for preoperative prediction of the risk of cholangiocarcinoma with perineural invasion.
    Wang M; Sun Z; Wang Q; Guo J; Li X; Chen J; Zhang B; Dai D; Feng Y
    Am J Cancer Res; 2023; 13(11):5082-5093. PubMed ID: 38058832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.